Return to Listing

2 result(s) for

PI Name Protocol # Title
Rachel Cook STUDY00016984 A Phase 1b Study Evaluating the Safety and Pharmacokinetics of Venetoclax as a Single-Agent and in Combination with Azacitidine in Subjects with Relapsed/Refractory Myelodysplastic Syndromes
Jennifer Saultz STUDY00018238 Phase I Study to Evaluate Safety of Ruxolitinib in Combination with Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080